November 16, 2021
“This paper recognize our pioneer role in the field of radiomics “With the most citations of the 10 leading co-cited authors, Philippe Lambin (from the Dpt […]
November 16, 2021
CP-506 can selectively eliminate hypoxic tumor cells. In our hands, CP-506 has several advantages compared to the previous HAP’s (see for example the very step curve […]
August 23, 2021
https://www.nature.com/articles/s43018-021-00236-2.epdf?sharing_token=KgtCNNhfYIHSXAlRKDoRwNRgN0jAjWel9jnR3ZoTv0PaqzLmM-RKhUiVyn1ERuyoe5QEvjLDx4PnnREswcxiagrd3l54oTv-p25UKrRkN2DnUQEtHvlBkjNcX3cQYh-h_QOBrEHxAwuhXjwtvB_FIVE3h1ifEb8mGMw8Olb2C20%3D
July 2, 2021
Our paper on combined prognostic signatures (clinical, biology, radiomics variables) on Head and Neck Cancer stage III-IVA is out (n=666 retrospective + 143 prospective patients, p<0.01, […]
June 1, 2021
Our article “Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost–Utility Study” […]
April 17, 2021
Eureka Today, Expert: Jan Theys In 1996 Jan Theys started his research as a PhD student in Leuven. In short: he uses the non-pathogenic bacterium Clostridium […]
October 12, 2020
Read the article on our ERC grant “Clostridium-based Immunotherapy” which has been published on the CORDIS website in six languages at: https://lnkd.in/g5AQSvR
October 5, 2020
Is schildklierkanker te ruiken in uitademingslucht? Zijn bacteriën naar tumoren te sturen om daar medicijnen te produceren? KWF Kankerbestrijding investeert 1,8 miljoen euro in 3 onderzoeken […]
October 5, 2020
https://www.maastrichtuniversity.nl/news/obtaining-research-grants-times-corona